The Curbsiders Addiction Medicine Podcast

From Recreational Use to Possible Therapeutic Interventions Learn how different hallucinogens act in the body and common dosing strategies. Appreciate the risks of use and the current state of hallucinogen research. We are joined in this episode by Dr. Albert Garcia-Romeu (Johns Hopkins Center for Psychedelic and Consciousness Research)  We are thrilled to produce Season 3 with support and partnership from The American College of Academic Addiction Medicine (ACAAM)!  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | [email protected] | Free CME! Show Segments Intro, disclaimer, guest bio Case from Kashlak; Definitions of hallucinogens and psychedelics Examples of hallucinogens and mechanisms of action Dosing strategies Risks of Use Psychedelic Assisted Therapy Outro Credits Producer, Writer, Show Notes, Infographic, Cover Art: Kat Mullins, MD Hosts: Shawn Cohen, MD and Kat Mullins, MD Reviewer: Kento Sonoda, MD Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Albert Garcia-Romeu, PhD

Maximize your treatment of alcohol-associated liver disease. Learn how to evaluate liver disease in patients with alcohol use disorder (AUD), choose AUD medications that are safe and effective, and identify patients who may be eligible for early liver transplantation. We’re joined by Dr. Lamia Haque, @lykhaque (Yale School of Medicine). We are thrilled to produce Season 3 with support and partnership from The American College of Academic Addiction Medicine (ACAAM)! Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | [email protected] | Free CME! Show Segments Intro, disclaimer, guest bio 0:00  Guest one-liner 3:10 Case from Kashlak 6:30 Epidemiology of alcohol-associated liver disease (ALD) 7:40 How does alcohol affect the liver? 11:11 Spectrum of ALD 13:10 Risk factors for ALD 16:13 Evaluating for ALD 19:35 When to refer to hepatology 33:08 Medications for AUD in patients with ALD 37:00 Monitoring liver tests for naltrexone 44:27 Optimizing treatment for patients who continue drinking 47:18 ALD and liver transplantation 50:45 Post-transplant care 1:00:15 Take-home points 1:02:30 Outro 1:04:56 Credits Writer and Producer: Kenneth Morford, MD Show Notes: Kenneth Morford, MD Infographic and Cover Art: Natalie Stahl, MD, MPH Hosts: Carolyn Chan, MD. MHS and Kenneth Morford, MD Reviewer: Sarah Leyde, MD Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Lamia Haque, MD, MPH

Spark your learning! We cover clinical pearls from graduating addiction medicine fellows by covering ACAAM’s annual lighting round presentation.  Learn about tianeptine, buprenorphine starts in patients with acute hepatitis, vaccinations for persons who inject drugs, and more!  We are thrilled to produce Season 3 with support and partnership from The American College of Academic Addiction Medicine (ACAAM)!  Claim CME for this episode at curbsiders.vcuhealth.org! Listening to this episode and completing CME, can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | [email protected] | Free CME! Credits Producer, Show Notes, Infographics: Carolyn Chan Hosts: Carolyn Chan, MD. MHS, Shawn Cohen, MD, Kenneth Morford, MD, Natalie Stahl, MD MPHS Reviewer: Sarah Leyde, MD Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Show Segments 00:00 Intro, disclaimer 03:00 Picks of the week 07:00 Buprenorphine and hepatitis 16:30 Ketamine for withdrawal 24:00 Hepatitis B 28:20 Tianeptine 35:30 Hepatitis C treatment 39:00 PETH 47:40 Unintended phenobarbital consequences 53:40 TBI and overdose risk 58:00 Outro

Expand your practice to include wound care for xylazine-related wounds and learn how to talk to your patients about harm reduction for xylazine. We are joined by Dr. Raagini Jawa (@Raaginizzle, UPMC) and Tehya Johnson, NP (@TehyaRJohnson, Boston Health Care for the Homeless).  We are thrilled to produce Season 3 with support and partnership from The American College of Academic Addiction Medicine (ACAAM)!  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | [email protected] | Free CME! Credits Show notes, infographics, cover art, writer and producer:  Zina Huxley-Reicher, MD  Hosts: Carolyn Chan, MD. MHS, Zina Huxley-Reicher, MD and Shawn Cohen, MD  Reviewer: Payel Jhoom Roy, MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guests: Raagini Jawa, MD MPH and Tehya Johnson, NP  Show Segments Intro, disclaimer, guest bios - 01:42  Guest one-liners - 03:22 Case from Kashlak - 7:56 Definition of xylazine, overview of xylazine in the drug supply and experience of use - 08:38 Xylazine test strips and other harm reduction strategies - 15:48 Natural history of xylazine wounds - 19:15 Creating a welcoming wound care environment - 21:05 Red flag symptoms indicating need for oral antibiotics and higher levels of care - 26:18 Steps for wound care - 33:27 Frequency of wound care - 46:16 Pain control in the setting of dressing changes - 51:01 Route switching, harm reduction around injecting at the site of the wound - 52:20 When to refer to other wound care specialists/plastic surgery - 55:00 Take home points - 57:05 Outro - 1:00:17